Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sear, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sear, J. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2002, Vol. 88, No. 6 757-760
© 2002 The Board of Management and Trustees of the British Journal of Anaesthesia


Editorial

Editorial II

Assessment of liver function: its application to outcome from liver transplantation

J. W. Sear1

1Nuffield Department of Anaesthetics, University of Oxford, Oxford, UK

The liver has a number of separate yet integrated functions. Assessment of hepatic behaviour during anaesthesia and the perioperative period generally involves tests that assess only part of the liver’s overall function, and assumes that behaviour in one area of activity reflects its function in other areas.

The functions of the liver can broadly be broken down into seven main areas: catabolic and anabolic functions with respect to carbohydrate, fat, and protein metabolism; production of bile; production and excretion of bilirubin; immunological functions involving the production and release of cytokines and interferons; scavenging and filtration of endotoxins and bacteria; storage of vitamin B12 and glycogen; and the biotransformation and elimination of drugs and xenobiotics.

While the hepatologist may use the prothrombin ratio or perhaps plasma pre-albumin concentrations (half-time 1–2 days) as a marker of the well-being of the liver for patients in acute liver failure, the chronic liver patient is . . . [Full Text of this Article]

Capacity-limited, binding-insensitive hepatic elimination
Capacity-limited, but binding-sensitive hepatic elimination (for example digitoxin, mexilitine, midazolam, erythromycin, and tolbutamide)
Flow-limited elimination
References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?